1357600-60-2Relevant academic research and scientific papers
Azaquinazoline Inhibitors Of Atypical Protein Kinase C
-
Paragraph 0348, (2015/12/24)
The present application provides a compound of formula (I) and/or a salt thereof, wherein R1, G, and X are as defined herein. A compound of formula (I) and/or its salts have aPKC inhibitory activity, and may be used to treat proliferative disor
Discovery of dehydro-oxopiperazine acetamides as novel bradykinin B1 receptor antagonists with enhanced in vitro potency
Qian, Wenyuan,Chen, Jian Jeffrey,Human, Jason,Aya, Toshihiro,Zhu, Jiawang,Biswas, Kaustav,Peterkin, Tanya,Hungate, Randall W.,Arik, Leyla,Johnson, Eileen,Kumar, Gondi,Joseph, Smriti,Jona, Janan,Guo, Hong-Xun,Wu, Zufan
, p. 1061 - 1067 (2012/03/11)
In a series of bradykinin B1 antagonists, we discovered that replacement of oxopiperazine acetamides with dehydro-oxopiperazine acetamides provided compounds with enhanced activity against the B1 receptor. The synthesis and SAR leading to potent analogs w
